Intranasal Vaccines Subject – Science and tech Context – Intranasal vaccine gets nod for phase 2/3 trials Concept – Nasal Covid Vaccine has been developed by Bharat Biotech called BBV154. Vaccine has successfully completed Phase 1 clinical trial in age groups of 18 to 60 years. According to the officials, doses of this […]

    INTRANASAL VACCINES Subject : Science & tech Context : While all COVID-19 vaccines administered through the intramuscular route have been found to reduce the chances of symptomatic disease and death, attempts are being made to develop vaccines that can potentially prevent or at least greatly reduce the chances of being infected and also […]